View Cart  
Fdanewsdrugdailybulletin

Jan. 18, 2005

Vol. 2 No. 12

View Archived Issues

Sign Up Now

CMS REPORT FINDS Rx DRUG SPENDING SLOWED IN 2003

Spending growth for prescription drugs in the U.S. decelerated at a rapid rate in 2003, according to new data released by the Centers for Medicare & Medicaid Services (CMS).

Read More

WYETH OK WITH CHANGES TO FEN-PHEN SETTLEMENT

Wyeth has agreed to support an amendment to a nationwide legal settlement with users of its fen-phen products -- a move that would guarantee payments to the largest group of members involved in the class action lawsuit.

Read More

ALLEGED GOP MEDIA PROPAGANDA SHOULD BE INVESTIGATED, DEMOCRATS SAY

Several prominent Democrats have sent a letter to the Government Accountability Office (GAO) asking the watchdog agency to examine "covert propaganda" being employed by the Bush administration, including actions related to the Medicare Modernization Act (MMA).

Read More

EXPERTS SAY LEAVE DRUG SAFETY OFFICE IN FDA, COX-2s ON THE MARKET

It would be a mistake to remove the FDA's drug safety office from the agency as a way to ensure total independence from the new drug office, says an industry expert who cautioned the FDA and lawmakers not to overreact to recent adverse events surrounding Cox-2 inhibitors.

Read More

AUSTRALIAN BIOTECH ACQUIRES MYOMATRIX

An Australian biotech company has acquired Myomatrix Therapeutics of Rensselaer, N.Y. Terms of the deal were not disclosed. Cytopia Inc., a wholly owned subsidiary of Cytopia Ltd., plans to add staff once the merger is completed. Shreefal Mehta, Myomatrix CEO, will be vice president of the merged entity.

Read More

ADDERALL XR-PARAGRAPH IV NOTICES UPDATE

Shire Pharmaceuticals remains committed to protecting the patents which it has relating to Adderall XR, its product for treatment of attention-deficit/hyperactivity disorder (ADHD).

Read More

YOUNG BIOTECH SNAGS PROMISING TECHNOLOGY

A Nashville biotech start-up has secured a global licensing pact for a new technology that detects, neutralizes and removes bacterial toxins.

Read More

QUINTILES ANNOUNCES PLANS TO CUT 316 ADDITIONAL JOBS

Quintiles Transnational has said its restructuring will cost an additional 316 jobs -- bringing the number of announced layoffs since November to 546.

Read More

CAREMARK SAYS PRODUCT SALES IN COMPLIANCE

Pharmacy benefits manager Caremark on Monday said all the products it sells come from licensed wholesalers, a day after a published report said Illinois regulators were investigating whether it resold drugs that had been returned by patients.

Read More

OXYGEN HEALTHCARE TO COMMISSION CHEMISTRY RESEARCH LAB AT A'BAD SOON

Oxygen Healthcare, promoted by a group of UK-based NRIs, is setting up a world-class research facility in Ahmedabad to offer contract chemistry in drug discovery for bio-pharmaceutical companies based in Europe and the U.S.

Read More

FIRM RECALLS ATTENTION-DEFICIT DRUG

A pharmaceutical company has issued a nationwide recall of approximately 500 bottles of a drug used to treat attention-deficit/hyperactivity disorder and narcolepsy.

Read More

WOMEN'S GROUPS PRESSURE FDA ON 'MORNING-AFTER' PILL

Women's rights groups seeking easier access to emergency contraception are pressuring U.S. regulators as they try to decide whether to approve a nonprescription "morning-after" pill.

Read More